Michael Karremann
Impact in
Papers in
- Genetics 14
- Glioma Diagnosis and Treatment 14
-
- Neuroblastoma Research and Treatments 8
- Barrier Structure and Function Studies 2
- Co-authors
- Torsten Pietsch (8 shared papers)Christof M. Kramm (9 shared papers)Gerrit H. Gielen (7 shared papers)Johannes Wolff (4 shared papers)Matthias Dürken (7 shared papers)Monika Warmuth‐Metz (3 shared papers)Marion Hoffmann (4 shared papers)Horst Schroten (7 shared papers)
- Journals
- Neuro-Oncology (3 papers)Journal of Neuro-Oncology (2 papers)International Journal of Molecular Sciences (2 papers)British Journal of Cancer (1 paper)Orphanet Journal of Rare Diseases (1 paper)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Michael Karremann
25 papers receiving 462 citations
Peers
Comparison fields: 5 of 63
- Genetics 279
- Neurology 143
- Cancer Research 54
- Structural Biology 5
- Epidemiology 120
Countries citing papers authored by Michael Karremann
This map shows the geographic impact of Michael Karremann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Karremann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Karremann more than expected).
Fields of papers citing papers by Michael Karremann
This network shows the impact of papers produced by Michael Karremann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Karremann. The network helps show where Michael Karremann may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Karremann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 170 | |
| 2 | 2020 | 40 | |
| 3 | 2008 | 32 | |
| 4 | 2008 | 23 | |
| 5 | 2013 | 22 | |
| 6 | 2015 | 22 | |
| 7 | 2009 | 19 | |
| 8 | 2018 | 18 | |
| 9 | 2020 | 17 | |
| 10 | 2021 | 16 | |
| 11 | 2020 | 16 | |
| 12 | 2008 | 14 | |
| 13 | 2019 | 11 | |
| 14 | 2014 | 11 | |
| 15 | 2020 | 10 | |
| 16 | 2025 | 5 | |
| 17 | 2020 | 5 | |
| 18 | 2017 | 4 | |
| 19 | 2015 | 4 | |
| 20 | 2020 | 4 |
About Michael Karremann
Michael Karremann is a scholar working on Genetics, Neurology, Molecular Biology, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine, having authored 27 papers that have together received 471 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (14 papers), Neuroblastoma Research and Treatments (8 papers), Acute Lymphoblastic Leukemia research (5 papers), Brain Metastases and Treatment (3 papers), MicroRNA in disease regulation (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Meningioma and schwannoma management (2 papers) and Barrier Structure and Function Studies (2 papers). The work is most often cited by research in Genetics (279 citations), Neurology (143 citations), Cancer Research (54 citations), Structural Biology (5 citations) and Epidemiology (120 citations). Michael Karremann has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Torsten Pietsch, Christof M. Kramm, Gerrit H. Gielen, Johannes Wolff, Matthias Dürken, Monika Warmuth‐Metz, Marion Hoffmann, Horst Schroten, Martin Benesch and Brigitte Bison. Their work appears in journals such as Neuro-Oncology, Journal of Neuro-Oncology, International Journal of Molecular Sciences, British Journal of Cancer and Orphanet Journal of Rare Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.